Evidence map›Paper›PMID 39279417›Full record

ArticleWorld psychiatry : official journal of the World Psychiatric Association (WPA)2024

Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+ cohort.

Simon Hartmann, Dominic Dwyer, Blake Cavve, Enda M Byrne, Isabelle Scott, Caroline Gao, Cassandra Wannan, Hok Pan Yuen, Jessica Hartmann, Ashleigh Lin and 22 more

Abstract read
In one paragraph

Article in World psychiatry : official journal of the World Psychiatric Association (WPA), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Early detection and intervention in at-risk mental states: rationale, structure, and clinical experience from a specialized outpatient service.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Repurposing medications to prevent psychosis.Npj mental health research · 2025
    Review
  11. Transforming Growth Factor-β Serum Levels Associated with Social Function in Subjects at Ultra-high Risk for Psychosis: A Multicenter Study.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Simon HartmannDiscipline of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
Dominic DwyerOrygen, Melbourne, VIC, Australia.
Blake CavveTelethon Kids Institute, University of Western Australia, Perth, WA, Australia.
Enda M ByrneSchool of Population and Global Health, University of Western Australia, Perth, WA, Australia.
Isabelle ScottOrygen, Melbourne, VIC, Australia.
Caroline GaoOrygen, Melbourne, VIC, Australia.
Cassandra WannanOrygen, Melbourne, VIC, Australia.
Hok Pan YuenOrygen, Melbourne, VIC, Australia.
Jessica HartmannOrygen, Melbourne, VIC, Australia.
Ashleigh LinSchool of Population and Global Health, University of Western Australia, Perth, WA, Australia.
Stephen J WoodOrygen, Melbourne, VIC, Australia.
Johanna T W WigmanDepartment of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Christel M MiddeldorpChild Health Research Centre, University of Queensland, St. Lucia, QLD, Australia.
Andrew ThompsonOrygen, Melbourne, VIC, Australia.
Paul AmmingerOrygen, Melbourne, VIC, Australia.
Monika SchlögelhoferBioPsyC - Biopsychosocial Corporation, Vienna, Austria.
Anita Riecher-RösslerMedical Faculty, University of Basel, Basel, Switzerland.
Eric Y H ChenDepartment of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.
Ian B HickieBrain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
Lisa J PhillipsMelbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia.
Miriam R SchäferOrygen, Melbourne, VIC, Australia.
Nilufar MossahebDepartment of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University of Vienna, Vienna, Austria.
Stefan SmesnyDepartment of Psychiatry, Jena University Hospital, Jena, Germany.
Gregor BergerDepartment of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
Lieuwe de HaanDepartment of Psychiatry, Academic Medical Center, Amsterdam, The Netherlands.
Merete NordentoftMental Health Center Copenhagen, Research Unit (CORE), Copenhagen, Denmark.
Swapna VermaInstitute of Mental Health, Singapore, Singapore.
Dorien H NiemanDepartment of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
Patrick D McGorryOrygen, Melbourne, VIC, Australia.
Alison R YungInstitute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia.
Scott R ClarkDiscipline of Psychiatry, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
Barnaby NelsonOrygen, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of ultra-high risk for psychosis (UHR) has been at the forefront of psychiatric research for several decades, with the ultimate goal of preventing the onset of psychotic disorder in high-risk individuals. Orygen (Melbourne, Australia) has led a range of observational and intervention studies in this clinical population. These datasets have now been integrated into the UHR 1000+ cohort, consisting of a sample of 1,245 UHR individuals with a follow-up period ranging from 1 to 16.7 years. This paper describes the cohort, presents a clinical prediction model of transition to psychosis in this cohort, and examines how predictive performance is affected by changes in UHR samples over time. We analyzed transition to psychosis using a Cox proportional hazards model. Clinical predictors for transition to psychosis were investigated in the entire cohort using multiple imputation and Rubin's rule. To assess performance drift over time, data from 1995-2016 were used for initial model fitting, and models were subsequently validated on data from 2017-2020. Over the follow-up period, 220 cases (17.7%) developed a psychotic disorder. Pooled hazard ratio (HR) estimates showed that the Comprehensive Assessment of At-Risk Mental States (CAARMS) Disorganized Speech subscale severity score (HR=1.12, 95% CI: 1.02-1.24, p=0.024), the CAARMS Unusual Thought Content subscale severity score (HR=1.13, 95% CI: 1.03-1.24, p=0.009), the Scale for the Assessment of Negative Symptoms (SANS) total score (HR=1.02, 95% CI: 1.00-1.03, p=0.022), the Social and Occupational Functioning Assessment Scale (SOFAS) score (HR=0.98, 95% CI: 0.97-1.00, p=0.036), and time between onset of symptoms and entry to UHR service (log transformed) (HR=1.10, 95% CI: 1.02-1.19, p=0.013) were predictive of transition to psychosis. UHR individuals who met the brief limited intermittent psychotic symptoms (BLIPS) criteria had a higher probability of transitioning to psychosis than those who met the attenuated psychotic symptoms (APS) criteria (HR=0.48, 95% CI: 0.32-0.73, p=0.001) and those who met the Trait risk criteria (a first-degree relative with a psychotic disorder or a schizotypal personality disorder plus a significant decrease in functioning during the previous year) (HR=0.43, 95% CI: 0.22-0.83, p=0.013). Models based on data from 1995-2016 displayed good calibration at initial model fitting, but showed a drift of 20.2-35.4% in calibration when validated on data from 2017-2020. Large-scale longitudinal data such as those from the UHR 1000+ cohort are required to develop accurate psychosis prediction models. It is critical to assess existing and future risk calculators for temporal drift, that may reduce their utility in clinical practice over time.

Indexed as

brief limited intermittent psychotic symptomsdisorganized speechnegative symptomsprediction model calibrationprediction of transition to psychosispsychosocial functioningtemporal validationUHR 1000+ cohortUltra‐high risk for psychosisunusual thought content

Identifiers

PMID39279417
PMCPMC11403190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.